All Regulation articles
-
OpinionUK budget aims to promote ‘reindustrialisation’
Chancellor affirmed funding for previously introduced support measures, but competitiveness challenges remain
-
PodcastA salmon-safe alternative to 6PPD & the first known example of naturally produced MOFs
Can we find a less toxic tyre additive while balancing delicate tyre chemistry? And we discuss a bacteria that appears to synthesise its own MOFs at the bottom of the seafloor.
-
OpinionUS atrazine cancer lawsuit revives hazard vs risk debate in pesticide regulation
Should firms have to issue cancer warnings in states that use different assessment criteria to national regulators?
-
BusinessTyremakers are searching for alternatives to salmon-killing additive
6PPD protects rubber from ozone, but forms a quinone that is extremely toxic to salmon
-
BusinessMerck & Co’s US antibiotic withdrawal sends the wrong signals for combating resistance
Loss of last-resort combination Recarbrio reignites questions on how to pay for crucial but rarely-used drugs
-
OpinionSanctions, regulation and prices restrict access to medicines
Having medicines available when we need them is a privilege, but access more globally is complex and relies on sometimes fragile supply systems.
-
BusinessUS watchdog calls for voluntary replacement for expired chemical plant security programme
Government Accountability Office urges reintroduction of vetting for terrorist threats
-
-
NewsEPA to revoke emissions limits on fossil fuel power plants
Trump administration estimates that its action will save over $300bn, but opponents criticise decision to ‘eliminate limits on climate pollution’
-
PodcastDrugging the ‘undruggable’ cancer proteins & conserving the Bayeux Tapestry
How did molecular glues help crack one of cancer’s toughest targets? And we explore the chemistry behind the investigation and conservation of the Bayeux Tapestry.
-
BusinessDeadly ammonia leak at fertiliser plant in Iraq
Two dead and 114 injured in incident at state-operated plant in Basra industrial area
-
Opinion‘Molecular glues’ are sticking it to cancer
Compounds that enhance selected protein–protein interactions to interfere with signalling or send proteins to be destroyed are making it possible to influence processes that were previously considered ‘undruggable’
-
BusinessProtein degrading breast cancer drugs navigate bumpy road to market
Camizestrant is now approved in US, UK and Europe despite uncertainty over long-term benefit, while vepdegestrant is approved in the US
-
BusinessUS approves pancreatic cancer treatment that targets ‘undruggable’ proteins
Daraxonrasib success offers hope of further approvals for Ras-inhibitor drug candidates targeting various cancers
-
BusinessProtein degrader approval offers hope to relapsed multiple myeloma patients
Highly potent molecular glue drug iberdomide doubles the number of patients reaching fewer than one myeloma cell per 100,000 in bone marrow
-
BusinessInvestigation flags chemical incompatibility in deadly US incident
Mixing nitric acid with sodium trithiocarbonate at Catalyst Refiners formed hydrogen sulfide
-
BusinessOral cholesterol-lowering peptide approved after a decade in development
Merck & Co’s Lipfendra (enlicitide) employs 13 enzymes in biocatalytic synthesis
-
PodcastThermo Fisher data manipulation & the shrinking chemical recycling industry
We discuss fabricated images in Thermo Fisher’s online catalogue. And, what barriers are preventing chemical plastic recycling from taking off?
-
NewsHouse of Lords committee calls for ban on over-the-counter flea and tick treatments
Overuse of these treatments is potentially causing widespread damage to the environment
-
BusinessEU relaxes methane and carbon emission rules
Methane regulation fines delayed carbon trading restrictions eased amid concerns over energy supply and security